Introduction Nonalcoholic fatty liver disease (NAFLD) has become a rising concern, often called a “sleeper epidemic.” Affecting roughly 1 in 4 pati…
Resmetirom: A New Treatment for NASH/MASH Resmetirom, marketed as Rezdiffra is set to become the first medication approved for nonalcoholic steat…